Elevation of two molecular forms of adrenomedullin in plasma and urine in patients with acute myocardial infarction treated with early coronary angioplasty
H Asakawa(Dokkyo University), Hiroaki Matsuoka(Social Welfare Department), Shigeo Horinaka(Dokkyo University), Kenji Kangawa(National Cerebral and Cardiovascular Center), Noriaki Tsuchiya(Dokkyo University), S Hara(Dokkyo University), Akihisa Yabe(Dokkyo University), Hiroshi Yagi(Kyushu University), Takeshi Suzuki(Dokkyo University), Yusuke Tsubokou(Dokkyo University), Toshio Nishikimi(Kyoto University)
Cited by 25
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Increased plasma levels of adrenomedullin in patients with heart failure
|Journal of the American College of Cardiology|1995|307